Surgery Partners Stock Forecast
NASDAQ: SGRYHealth CareHospital/Nursing ManagementUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 13.89 0.00%
SGRY analyst consensus
Consensus (12 analysts)
buy
Avg. price target
$18.82+35.49%
- Strong buy 1
- Buy 8
- Hold 3
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 12 Wall Street analysts covering Surgery Partners (2026-10-09), 9 rate the stock a buy or strong buy, 3 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $18.82, with a high estimate of $24.00 and a low estimate of $14.00. The average target implies upside of 35.5% from the current price of $13.89.
The spread between the highest and lowest targets is 71.4%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for SGRY.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 1 | 8% |
| Buy | 8 | 67% |
| Hold | 3 | 25% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-09.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $14.00 | +0.79% |
| Average target | $18.82 | +35.49% |
| High target | $24.00 | +72.79% |